Antimicrobial susceptibility pattern of nosocomial Gram negative pathogens: Results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004);Hastane enfeksiyonu etkeni gram negatif bakterilerin çesi̧tli antimikrobiyal ajanlara karşι duyarlιlιk durumu: Hacettepe Üniversitesi Erişkin Hastanesi MYSTIC çalιşmasι verisi (2000-2004)

Mikrobiyoloji Bulteni

Volumn 40, Issue 3, 2006, Pages 147-154

  Zarakolu, Pinar ^a   Hasçelik, Gülşen ^a   Ünal, Serhat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Antimicrobial susceptibility; Escherichia coli; Klebsiella pneumoniae; MYSTIC; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ARTICLE; BIOSYNTHESIS; CROSS INFECTION; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; TURKEY (REPUBLIC);

ACINETOBACTER BAUMANNII; ANTI-INFECTIVE AGENTS; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; TURKEY;

EID: 39049181418     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Masterton R. Surveillance studies: how can they help the management of the infection? J Antimicrob Chemother 2000; 46: 53-8.
2. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
3. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20: 271-4.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th Informational Supplement. Document M100-A15. 2005. CLSI, Wayne, Pa.
5. Cormican MG, Marshall SA, Jones RN. Detection of extended-spectrum β-lactamases producing strains by the E-test ESBL screen. J Clin Microbiol 1996; 34: 1880-4.
6. Gaynes R, Edwards JR and National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41: 848-54.
7. The Turkish Antimicrobial Resistance Study Group, Pfaller MA, Korten V, Jones RN, Doern GV. Multicenter evaluation of the antimicrobial activity for seven broad-spectrum β-lactams in Turkey using the Etest method. Diagn Microbiol Infect Dis 1999; 35: 65-73.
8. Babini GS, Livermore DM. Antimicrobial resistance among Klebsiella spp. collected from intansive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother 2000; 45: 183-9.
9. Goossens H. MYSTIC Study Group (Europe): MYSTIC program: Summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis 2001; 41: 183-9.
10. Günseren F, Mamikoǧlu L, Öztürk S, et al. A surveillance study of antimicrobial resistance of Gram negative bacteria isolated from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother 1999; 43: 373-8.
11. Aksaray S, Dokuzoǧuz B, Güvener E, et al. Surveillance of antimicrobial resistance of Gram negative bacteria isolated from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother 2000; 45: 695-9.
12. Leblecioǧlu H, Günaydin M, Esen S, et al. Surveillance of antimicrobial resistance in Gram negative isolates from intensive care units in Turkey: analysis of data from the last 5 years. J Antimicrob Chemother 2002; 14: 140-6.
13. Küçükateş E. Antimicrobial resistance among gram-negative bacteria isolated from intensive care units in a cardiology institute in Istanbul, Turkey: Jpn J Infect Dis 2005; 58: 228-31.
14. Akata F, Tatman M, Ozkan E, Tansel O, Otkun M, Tugrul M. Prevalence of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae in Trakya University Hospital, Turkey. New Microbiol 2003; 26: 257-62.
15. Durmaz R, Durmaz B, Koroglu M, Tekerekoglu MS. Detection and typing of extended-spectrum beta-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey. Microb Drug Resist 2001; 7: 171-5.
16. Gulay Z, Thomson CJ, Yulug N, Amyes SG. High prevalence of extended spectrum beta-lactamase production among Klebsiella pneumoniae strains isolated at a University Hospital in Turkey. J Chemother 2000; 12): 145-52.
17. Livermore DM, Nichols T, Lamagni TL, Potz N, Reynolds R, Duckworth G. Ciprofloxacin resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men. J Antimicrob Chemother 2003; 52: 1040-2.
18. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003; 47: 3724-32.
19. Kang CI, Kim SH, Kim DM, Park WB. Risk factors for ciprofloxacin resistance in bloodstream infections due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist 2004; 10: 71-6.
20. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading, recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 2001; 48 (Suppl 1): 87-102.
21. Akan OA. Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002. Mikrobiyol Bul 2003; 37: 241-6.
22. Turner PJ. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997-2002). Diagn Microbiol Infect Dis 2005; 51: 281-9.
23. Midilli K, Aygün G, Kuskucu M ve ark. Klebsiella pneumoniae suşunda saptanan yeni bir metallobeta-laktamaz varyantr: VIM-5. Klinik Mikrobiyoloji ve infeksiyon Hastalikan Demeǧi KLIMIK Kongresi, Istanbul. Özet Kitabi, s: 275.
24. Över U, Gür D, Ünal S, Miller GH, the Aminoglycoside Resistance Study Group. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin Microbiol Infect 2001; 7: 470-8.
25. Masterton RG. Ciprofloxacin resistance 'early-warning' signs from the MYSTIC surveillance program. J Antimicrob Chemother 2002; 49: 218-9.